KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Johnson & Johnson (JNJ) EBT Margin (2016 - 2025)

Johnson & Johnson's EBT Margin history spans 17 years, with the latest figure at 20.22% for Q4 2025.

  • For Q4 2025, EBT Margin rose 296.0% year-over-year to 20.22%; the TTM value through Dec 2025 reached 34.59%, up 1580.0%, while the annual FY2025 figure was 34.59%, 1580.0% up from the prior year.
  • EBT Margin for Q4 2025 was 20.22% at Johnson & Johnson, down from 31.23% in the prior quarter.
  • Across five years, EBT Margin topped out at 62.26% in Q1 2025 and bottomed at 6.16% in Q2 2023.
  • The 5-year median for EBT Margin is 24.94% (2022), against an average of 23.12%.
  • The largest annual shift saw EBT Margin plummeted -3238bps in 2023 before it skyrocketed 4489bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 16.49% in 2021, then surged by 57bps to 25.87% in 2022, then fell by -13bps to 22.56% in 2023, then dropped by -23bps to 17.26% in 2024, then grew by 17bps to 20.22% in 2025.
  • Per Business Quant, the three most recent readings for JNJ's EBT Margin are 20.22% (Q4 2025), 31.23% (Q3 2025), and 27.34% (Q2 2025).